Michelle Dipp Joins Women’s Foundation of Boston’s Board of Directors
Boston-based nonprofit, Women’s Foundation of Boston is pleased to announce the formation of their official Board of Directors. WFBoston’s Board of Directors is comprised of community, nonprofit, and business leaders, one of which is Biospring Partner’s Michelle Dipp.
With more than ten years of experience in investing in Life Sciences startups, Michelle Dipp, MD PhD is the co-founder and managing partner of Biospring Partners. It is a private equity and venture capital firm that invests in growth-stage Life Sciences Technology companies.
Prior to this, she was the Managing Director of General Atlantic and the Head of Centre of Excellence for External Drug Discovery for GlaxoSmithKline (GSK). Michelle Dipp is also a member of the Trustee Advisory Board for Beth Israel Deaconess, World Economic Forum’s Young Global Leaders, and one of the contributors at Thrive Global.
Meanwhile, WFBoston is committed to providing economic and leadership opportunities to the women of Greater Boston. They also promote philanthropic giving to organizations that help women to be financially independent and valued community leaders.
About Biospring Partners
Founded in 2020 by Michelle Dipp, MD PhD and Jennifer Lum, Biospring Partners invests in growth-stage Life Sciences Technology companies. The venture capital firm leverages its extensive industry experience to support B2B enterprise software, tools, and services that help innovate businesses in the Life Sciences sector.
About Women’s Foundation of Boston
The WFBoston was established by Boston residents and philanthropists Christina Suh, Ami Danoff, and Christina Gordon in 2017. It is a 501(c)(3) nonprofit organization that is meant to drive economic empowerment for women of Greater Boston. They help create, fund, and accelerate programs that enable women to be successful leaders of the community.